ConductScience.org, home

Paper21545189

Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.

Krol M and 3 others. Pharmacoeconomics, 2011. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Papers, record 21545189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21545189

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.
PubMed
Journal
Pharmacoeconomics
PubMed
Year
2011
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
3.87
iCite
Revised in PubMed
2025-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krol MMarieke
2Papenburg JJocé
3Koopmanschap MMarc
4Brouwer WWerner

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Depressive DisorderMajor topic
EfficiencyMajor topic
Health Care CostsMajor topic
Cost Savings
Cost of Illness
Costs and Cost Analysis
Humans
Regression Analysis

Source PubMed

Download CSV of topics

References116

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110520672Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.Med Decis Making1999https://conductscience.org/library/papers/10520672PubMed
217454724A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.Nord J Psychiatry2007https://conductscience.org/library/papers/17454724PubMed
312395027Cost-effectiveness of a program to prevent depression relapse in primary care.Med Care2002https://conductscience.org/library/papers/12395027PubMed
49727728Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo.Int Clin Psychopharmacol1998https://conductscience.org/library/papers/9727728PubMed
513688369An inventory for measuring depression.Arch Gen Psychiatry1961https://conductscience.org/library/papers/13688369PubMed
618458973Do quality-adjusted life years take account of lost income? Evidence from an Australian survey.Eur J Health Econ2009https://conductscience.org/library/papers/18458973PubMed
711294131Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study.Acta Medica (Hradec Kralove)2000https://conductscience.org/library/papers/11294131PubMed
89435921The impact of indirect costs on outcomes of health care programs.Health Econ1994https://conductscience.org/library/papers/9435921PubMed
98269048QALY league tables: handle with care.Health Econ1993https://conductscience.org/library/papers/8269048PubMed
1011318082Dealing with skewed data: an example using asthma-related costs of medicaid clients.Clin Ther2001https://conductscience.org/library/papers/11318082PubMed
1116816306
Cost-effectiveness of referral for generic care or problem-solving treatment from community mental health nurses, compared with usual general practitioner care for common mental disorders: Randomised controlled trial.
Br J Psychiatry2006https://conductscience.org/library/papers/16816306PubMed
1211705185Health economic guidelines--similarities, differences and some implications.Value Health2001https://conductscience.org/library/papers/11705185PubMed
1317874482A budget-impact and cost-effectiveness model for second-line treatment of major depression.J Manag Care Pharm2007https://conductscience.org/library/papers/17874482PubMed
1410414837Production gains from health care: what should be included in cost-effectiveness analyses?Soc Sci Med1999https://conductscience.org/library/papers/10414837PubMed
1511010234On the economic foundations of CEA. Ladies and gentlemen, take your positions!J Health Econ2000https://conductscience.org/library/papers/11010234PubMed
169892305Earnings changes for depressed individuals treated by mental health specialists.Am J Psychiatry1999https://conductscience.org/library/papers/9892305PubMed
1716299434Managed care and systems cost-effectiveness: treatment for depression.Med Care2005https://conductscience.org/library/papers/16299434PubMed
1810165316Changing patterns of antidepressant use and costs in a health maintenance organisation.Pharmacoeconomics1997https://conductscience.org/library/papers/10165316PubMed
1912706517When the cradle falls II: The cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care.J Affect Disord2003https://conductscience.org/library/papers/12706517PubMed
2015521793A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.CNS Drugs2004https://conductscience.org/library/papers/15521793PubMed

See all 116 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
42385012[Disease, social, and economic burden of smoking in Brazil and the impact of tax increases on the economy and on the reduction of morbidity and mortality].Cad Saude Publica2026https://conductscience.org/library/papers/42385012PubMed
41948287The hidden costs of Dutch dietary choices: quantifying the health and environmental costs attributable to suboptimal diets.Front Nutr2026https://conductscience.org/library/papers/41948287PubMed
40553408Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations.Pharmacoecon Open2025https://conductscience.org/library/papers/40553408PubMed
39979658Routine measurement in low back pain; towards a pragmatic patient-reported productivity cost outcome measurement using the institute for medical technology assessment productivity cost questionnaire.Eur J Health Econ2025https://conductscience.org/library/papers/39979658PubMed
37592122Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review.Pharmacoeconomics2023https://conductscience.org/library/papers/37592122PubMed
37530935Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs.Pharmacoeconomics2023https://conductscience.org/library/papers/37530935PubMed
36960361The association between health costs and physical inactivity; analysis from the Physical Activity at Work study in Thailand.Front Public Health2023https://conductscience.org/library/papers/36960361PubMed
36856941Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects.Pharmacoeconomics2023https://conductscience.org/library/papers/36856941PubMed
36564501A novel set of Austrian reference unit costs for comprehensive societal perspectives consistent with latest European costing methods for economic evaluations.Wien Klin Wochenschr2024https://conductscience.org/library/papers/36564501PubMed
36510211A systemmatic literature review on indirect costs of women with breast cancer.Cost Eff Resour Alloc2022https://conductscience.org/library/papers/36510211PubMed
36219271Out-of-pocket Expenses and Time Spent on Clinic Visits Among HIV Pre-exposure Prophylaxis Users and Other Clinic Attendees in Eswatini.AIDS Behav2023https://conductscience.org/library/papers/36219271PubMed
36205907Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders.Adv Ther2022https://conductscience.org/library/papers/36205907PubMed
36005943Economic evaluation of psychological treatments for common mental disorders in low- and middle-income countries: a systematic review.Health Policy Plan2023https://conductscience.org/library/papers/36005943PubMed
35977755Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China.BMJ Glob Health2022https://conductscience.org/library/papers/35977755PubMed
35909186A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria.Dermatol Ther (Heidelb)2022https://conductscience.org/library/papers/35909186PubMed
35436874The economic burden of knee and hip osteoarthritis: absenteeism and costs in the Dutch workforce.BMC Musculoskelet Disord2022https://conductscience.org/library/papers/35436874PubMed
35247183The Road to Recovery for Patients with Depression: From Treatment Initiation to Treatment Continuity.Adv Ther2022https://conductscience.org/library/papers/35247183PubMed
34767575
Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.
PLoS One2021https://conductscience.org/library/papers/34767575PubMed
34656083Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs.BMC Nephrol2021https://conductscience.org/library/papers/34656083PubMed
34514969Economic evaluations of psychological treatments for common mental disorders in low- and middle-income countries: protocol for a systematic review.Glob Health Action2021https://conductscience.org/library/papers/34514969PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21545189

GET https://conductscience.org/api/papers/v1/21545189/references?page=2